Compound Detail
CHEMBL2218861
QUINAGOLIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2218861 |
| Name | QUINAGOLIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | GDFGTRDCCWFXTG-UHFFFAOYSA-N |
4
Targets
18
Activities
1
Assay Types
0
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
395.6
MW (Da)
2.14
ALogP
4
HBA
2
HBD
72.9
PSA (Ų)
0.74
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2004 |
| Availability | Unknown |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor agonist | AGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Ovarian Hyperstimulation Syndrome
ATC Classification
G02CB04
quinagolide
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS
Activity Summary
IC50 18 meas. best 7.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dopamine receptor CHEMBL2096970 | IC50 | 7.72 | 7.1533 | 19.0 | 6 |
| Serotonin (5-HT) receptor CHEMBL2094123 | IC50 | 5.64 | 5.4 | 2300.0 | 6 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 5.25 | 5.21 | 5600.0 | 3 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 5.22 | 5.1467 | 6000.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 4045929 | 10.1021/jm00148a030 | Dopamine receptor | 6 |
| 4045929 | 10.1021/jm00148a030 | Serotonin (5-HT) receptor | 6 |
| 4045929 | 10.1021/jm00148a030 | Rattus norvegicus | 3 |
| 4045929 | 10.1021/jm00148a030 | Adrenergic receptor alpha-2 | 3 |
| 4045929 | 10.1021/jm00148a030 | Adrenergic receptor alpha-1 | 3 |
| 3973904 | 10.1021/jm00381a017 | Rattus norvegicus | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 3973904 | 10.1021/jm00381a017 | Serotonin (5-HT) receptor | 2 |
| 3973904 | 10.1021/jm00381a017 | Dopamine receptor | 2 |
Data from ChEMBL 36 via Core Engine